AI assistant
10x Genomics, Inc. — Director's Dealing 2021
Jul 6, 2021
31830_dirs_2021-07-06_a969d377-4613-426f-871a-a9331a9604fd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-07-01
Reporting Person: McAnear Justin J. (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-01 | Class A Common Stock | M | 10000 | $5.04 | Acquired | 49370 | Direct |
| 2021-07-01 | Class A Common Stock | S | 2700 | $189.8522 | Disposed | 46670 | Direct |
| 2021-07-01 | Class A Common Stock | S | 2800 | $190.6638 | Disposed | 43870 | Direct |
| 2021-07-01 | Class A Common Stock | S | 1500 | $191.7347 | Disposed | 42370 | Direct |
| 2021-07-01 | Class A Common Stock | S | 800 | $192.9473 | Disposed | 41570 | Direct |
| 2021-07-01 | Class A Common Stock | S | 1400 | $193.7629 | Disposed | 40170 | Direct |
| 2021-07-01 | Class A Common Stock | S | 700 | $194.8054 | Disposed | 39470 | Direct |
| 2021-07-01 | Class A Common Stock | S | 100 | $195.82 | Disposed | 39370 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-07-01 | Stock Option (right to buy) | $5.04 | M | 10000 | Disposed | 2028-11-02 | Class A Common Stock (10000) | Direct |
Footnotes
F1: This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2: Includes an aggregate of 359 shares previously acquired under the Issuer's 2019 Employee Stock Purchase Plan.
F3: This transaction was executed in multiple trades at prices ranging from $189.24 to $190.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4: This transaction was executed in multiple trades at prices ranging from $190.25 to $191.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5: This transaction was executed in multiple trades at prices ranging from $191.32 to $192.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6: This transaction was executed in multiple trades at prices ranging from $192.32 to $193.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7: This transaction was executed in multiple trades at prices ranging from $193.38 to $194.35. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8: This transaction was executed in multiple trades at prices ranging from $194.40 to $195.39. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9: This option, originally for 600,000 shares, of which 189,841 shares have been exercised, vested as to one-fourth of the shares on October 8, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.